Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
Botulinum toxin type A injections represent an important therapeutic option for patients with neurogenic urinary dysfunction in whom conservative treatment has not been effective. The nurse's role in ensuring that these patients receive appropriate assessment and treatment is discussed.
UPMC Multiple Sclerosis Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Margie
M
O'Leary
Mary
M
Dierich
D000283:Administration, Intravesical; D019274:Botulinum Toxins, Type A / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D016527:Drug Costs; D006801:Humans; D009465:Neuromuscular Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D024802:Nurse's Role; D009730:Nursing Assessment; D056687:Off-Label Use; D010353:Patient Education as Topic; D018579:Patient Selection; D011788:Quality of Life; D012051:Reimbursement Mechanisms; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A